New reports from Israel have indicated a probable link between Pfizer’s experimental COVID-19 jab and myocarditis (inflammation of the heart muscle).
From December 2020 to May 2021, 275 cases of myocarditis were reported amongst Israel’s vaccinated population.
A deeper dive into the findings show that it’s mostly young men in the 16-30 age demographic being affected by this severe side effect.
In particular, 16-19 year-old men.
And usually after the 2nd dose of the experimental jab.
These disturbing findings hit close to home since I’m included in that 16-30 age bracket.
For a virus with a 99.99% survival rate in this age demographic, do hundreds (or possibly thousands) of myocarditis cases justify this experimental jab?
And that’s only referring to Israel.
Who knows how many diagnosed and undiagnosed myocarditis cases exist in the astronomically larger United States?
And the most disgusting part of this matter, the medical overlords in Israel will allow 12-15 year-olds to receive the experimental jab.
That’s the same direction the United States took weeks ago when the FDA gave the experimental jabs Emergency Use Authorization for 12-15 year-olds.
More from Israel:
The #COVID19 vaccine made by Pfizer and BioNTech appears to put young men at elevated risk of developing a heart muscle inflammation called myocarditis, researchers in Israel say. https://t.co/G9zveH6QdM
— News from Science (@NewsfromScience) June 1, 2021
— Will Meade (@realwillmeade) June 2, 2021
— Streetinsider.com (@Street_Insider) June 2, 2021
In Israel, 275 cases of myocarditis were reported between December 2020 and May 2021 among more than 5 million vaccinated people, the ministry said in disclosing the findings of a study it commissioned to examine the matter. https://t.co/MSCYOhcLII
— Deccan Herald (@DeccanHerald) June 2, 2021
Israel health officials say they have found a probable link between Pfizer and BioNTech's coronavirus vaccine and dozens of cases of heart inflammation in young men after the second dose https://t.co/eQkNObfoRV
— Bloomberg Middle East (@middleeast) June 2, 2021
As Israel prepares mass vaccination of teenagers, Health Ministry report finds vaccine likely the cause of hundreds of cases of myocarditis https://t.co/f5pSV6ih8l
— Arutz Sheva (@ArutzSheva_En) June 2, 2021
NEWS ALERT FROM REUTERS: Probable link between myocarditis and Pfizer vaccine in young people in Israel. Vaccinating 12-15 year olds ON HOLD. pic.twitter.com/9eaULv7aRv
— Scott Jensen (@drscottjensen) June 2, 2021
Jeffrey Heller, Jun 1, Israel sees probable link between Pfizer and myocarditis cases. GOF Spike protein circulates for two weeks after shot damaging the heart. Tip of the iceberg. Check troponin blood test and ECG in adolescent victims. https://t.co/HKDmW6O1mv
— COVID-19 Evidence-Based Clinical Response Panel (@cov19treatments) June 2, 2021
Israel’s Health Ministry said on Tuesday it had found the small number of heart inflammation cases observed mainly in young men who received Pfizer’s (PFE.N) COVID-19 vaccine in Israel were likely linked to their vaccination.
Pfizer has said it has not observed a higher rate of the condition, known as myocarditis, than would normally be expected in the general population.
In Israel, 275 cases of myocarditis were reported between December 2020 and May 2021 among more than 5 million vaccinated people, the ministry said in disclosing the findings of a study it commissioned to examine the matter.
Most patients who experienced heart inflammation spent no more than four days in the hospital and 95% of the cases were classified as mild, according to the study, which the ministry said was conducted by three teams of experts.
The study found “there is a probable link between receiving the second dose (of Pfizer) vaccine and the appearance of myocarditis among men aged 16 to 30,” it said in a statement. According to the findings, such a link was observed more among men aged 16 to 19 than in other age groups.
The European Medicines Agency (EMA) said last week that heart inflammation following vaccination with Comirnaty had been no cause for concern as they continued to happen at a rate that typically affected the general population. It added at the time that young men were particularly prone to the condition. read more
A U.S. Centers for Disease Control and Prevention advisory group last month recommended further study of the possibility of a link between myocarditis and mRNA vaccines, which include those from Pfizer and Moderna Inc.
Zero Hedge added commentary:
Pfizer said in a statement that it had reviewed the Israeli observations of myocarditis, noting that no link to its vaccine has been confirmed.
“A careful assessment of the reports is ongoing and it has not been concluded,” Pfizer said. “Adverse events, including myocarditis and pericarditis, are being regularly and thoroughly reviewed by the companies as well as by regulatory authorities.”
Meanwhile, Nachman Ash, Israel’s pandemic-response coordinator, told local radio station Radio 103 FM, “the health committee gave the green light for vaccinating 12- to 15-year-olds, and this will be possible as of next week.”
An advisory group with the U.S. Centers for Disease Control and Prevention recommended last month further examination into the possible link between myocarditis and mRNA vaccines.
The handful of myocarditis cases seem to outweigh the positives as more than 55% of Israel’s population has already been vaccinated.
While the country continues a vaccination spree, what’s not being widely spoken about is a new study that suggests natural immunity to the virus could last a lifetime.
My question for anyone in the 16-30 age demographic (especially men), would you feel comfortable taking the experimental jab knowing this potential risk?